1. Home
  2. TRUE vs OBIO Comparison

TRUE vs OBIO Comparison

Compare TRUE & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRUE
  • OBIO
  • Stock Information
  • Founded
  • TRUE 2005
  • OBIO 2017
  • Country
  • TRUE United States
  • OBIO United States
  • Employees
  • TRUE N/A
  • OBIO N/A
  • Industry
  • TRUE Computer Software: Programming Data Processing
  • OBIO Medicinal Chemicals and Botanical Products
  • Sector
  • TRUE Technology
  • OBIO Health Care
  • Exchange
  • TRUE Nasdaq
  • OBIO Nasdaq
  • Market Cap
  • TRUE 175.1M
  • OBIO 172.1M
  • IPO Year
  • TRUE 2014
  • OBIO N/A
  • Fundamental
  • Price
  • TRUE $2.20
  • OBIO $3.89
  • Analyst Decision
  • TRUE Hold
  • OBIO Strong Buy
  • Analyst Count
  • TRUE 5
  • OBIO 4
  • Target Price
  • TRUE $3.28
  • OBIO $14.00
  • AVG Volume (30 Days)
  • TRUE 1.4M
  • OBIO 366.4K
  • Earning Date
  • TRUE 11-05-2025
  • OBIO 11-12-2025
  • Dividend Yield
  • TRUE N/A
  • OBIO N/A
  • EPS Growth
  • TRUE N/A
  • OBIO N/A
  • EPS
  • TRUE N/A
  • OBIO N/A
  • Revenue
  • TRUE $184,559,000.00
  • OBIO $2,944,000.00
  • Revenue This Year
  • TRUE $9.14
  • OBIO $31.43
  • Revenue Next Year
  • TRUE $7.47
  • OBIO $10.87
  • P/E Ratio
  • TRUE N/A
  • OBIO N/A
  • Revenue Growth
  • TRUE 11.66
  • OBIO 41.61
  • 52 Week Low
  • TRUE $1.05
  • OBIO $2.20
  • 52 Week High
  • TRUE $4.62
  • OBIO $6.50
  • Technical
  • Relative Strength Index (RSI)
  • TRUE 52.04
  • OBIO 59.10
  • Support Level
  • TRUE $2.15
  • OBIO $3.67
  • Resistance Level
  • TRUE $2.48
  • OBIO $4.01
  • Average True Range (ATR)
  • TRUE 0.07
  • OBIO 0.31
  • MACD
  • TRUE -0.02
  • OBIO -0.02
  • Stochastic Oscillator
  • TRUE 40.62
  • OBIO 72.37

About TRUE TrueCar Inc.

TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. The Company has one operating segment, with three distinct service offerings: Dealer products and services, OEM incentives, and other.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Share on Social Networks: